A novel phenylsulfonamide ameliorates scopolamine-induced cognitive impairment in a mouse model.
Novel level-5 chemistry finding; leaves open any cardiovascular relevance or application.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: